We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+3.56%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.99B
AUM Growth
-$200M
Cap. Flow
+$955M
Cap. Flow %
19.13%
Top 10 Hldgs %
53.63%
Holding
424
New
126
Increased
60
Reduced
38
Closed
165

Top Buys

Rank Stock Value
1
ANDV
Andeavor
ANDV
+$273M
2
XL
XL Group Ltd.
XL
+$104M
3
ESRX
Express Scripts Holding Company
ESRX
+$97.2M
4
EVHC
Envision Healthcare Holdings Inc
EVHC
+$88.3M
5
CI icon
Cigna
CI
+$69.2M

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$526M
2
TWX
Time Warner Inc
TWX
+$279M
3
AET
Aetna Inc
AET
+$126M
4
MSCC
Microsemi Corp
MSCC
+$48.9M
5
MHK icon
Mohawk Industries
MHK
+$44.9M

Sector Composition

Rank Sector Weight
1 Technology 20.53%
2 Financials 18.74%
3 Communication Services 6.93%
4 Energy 6.62%
5 Healthcare 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENDP
176
PUT
DELISTED
Endo International plc
ENDP
$1.22M 0.02%
+2,020,500
New +$13.6M
ESS icon
177
Essex Property Trust
ESS
$18.3B
$1.22M 0.02%
+5,100
New +$1.21M
MAC icon
178
Macerich
MAC
$6.66B
$1.22M 0.02%
+21,400
New +$1.21M
KURA icon
179
Kura Oncology
KURA
$824M
$1.2M 0.02%
66,157
-4,100
-6% -$69.4K
URGN icon
180
UroGen Pharma
URGN
$2.22B
$1.13M 0.02%
+22,659
New +$1.32M
SMPL icon
181
CALL
Simply Good Foods
SMPL
$988M
$1.13M 0.02%
270,000
-7,860
-3% -$105K
ITRM
182
DELISTED
Iterum Therapeutics
ITRM
$1.09M 0.02%
+6,667
New +$1.2M
KIN
183
DELISTED
Kindred Biosciences, Inc.
KIN
$1.06M 0.02%
+100,000
New +$975K
HYG icon
184
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$1.04M 0.02%
1,500,000
– –
NSLR
185
Neostellar Capital Corp
NSLR
$255M
$1.03M 0.02%
+178,692
New +$1.05M
SKT icon
186
Tanger
SKT
$4.52B
$1.03M 0.02%
+43,700
New +$961K
VCEL icon
187
Vericel Corp
VCEL
$2.29B
$913K 0.02%
+94,150
New +$1.17M
TSLA icon
188
PUT
Tesla
TSLA
$1.26T
$867K 0.02%
+483,000
New +$9.82M
AKAO
189
DELISTED
Achaogen Inc
AKAO
$866K 0.02%
+100,000
New +$1.22M
DNTH icon
190
Dianthus Therapeutics
DNTH
$6.15B
$810K 0.02%
+3,750
New +$846K
EA icon
191
CALL
Electronic Arts
EA
$793K 0.02%
938,600
-101,400
-10% -$13.2M
FTR
192
PUT
DELISTED
Frontier Communications Corp.
FTR
$783K 0.02%
+405,000
New +$3.3M
ADT icon
193
ADT
ADT
$5.59B
$778K 0.02%
+90,000
New +$747K
GFF icon
194
Griffon
GFF
$4.88B
$740K 0.01%
+41,595
New +$856K
GPRO icon
195
GoPro
GPRO
$126M
$644K 0.01%
+100,000
New +$557K
CDP icon
196
COPT Defense Properties
CDP
$4.22B
$638K 0.01%
22,000
-25,800
-54% -$707K
ESRT icon
197
Empire State Realty Trust
ESRT
$843M
$617K 0.01%
36,100
-110,200
-75% -$1.86M
APPN icon
198
Appian
APPN
$2.23B
$595K 0.01%
16,461
-93,338
-85% -$2.89M
NVR icon
199
NVR
NVR
$16.9B
$594K 0.01%
+200
New +$612K
WH icon
200
Wyndham Hotels & Resorts
WH
$5.58B
$588K 0.01%
+10,000
New +$616K
6 7
8
9 10

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q2 2018 Portfolio in Review

As of Q2 2018, UBS O'Connor held 424 positions worth $4.99B, down 3.9% from $5.19B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

UBS O'Connor deployed $955M of net new capital in Q2 2018, opening 126 new positions and adding to 60 existing holdings. Its largest new stake was Envision Healthcare Holdings Inc: 2,150,000 shares worth $94.6M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Aetna Inc, an estimated $126M trimmed.

  • UBS O'Connor's largest Q2 2018 buy was Envision Healthcare Holdings Inc: 2,150,000 shares worth $94.6M.
  • UBS O'Connor added most to Andeavor in Q2 2018, an estimated $273M increase.
  • UBS O'Connor's biggest Q2 2018 reduction was Aetna Inc, cutting an estimated $126M.
  • UBS O'Connor fully exited Monsanto Co in Q2 2018, selling an estimated $526M.
  • UBS O'Connor's ten largest holdings make up 54% of its $4.99B portfolio in Q2 2018.
  • UBS O'Connor opened 126 new positions and closed 165 in Q2 2018.
  • UBS O'Connor's portfolio value fell 3.9% quarter-over-quarter to $4.99B.

Based on UBS O'Connor's 13F filing for Q2 2018, filed 14 Aug 2018.